1
|
Sever MS, Steinmuller DR, Hayes JM, Streem
SB and Novick AC: Pericarditis following renal transplantation.
Transplantation. 51:1229–1232. 1991. View Article : Google Scholar : PubMed/NCBI
|
2
|
Alpert MA and Ravenscraft MD: Pericardial
involvement in end-stage renal disease. Am J Med Sci. 325:228–236.
2003. View Article : Google Scholar : PubMed/NCBI
|
3
|
Maisch B, Seferović PM, Ristić AD, et al;
Task Force on the Diagnosis and Management of Pericardial Diseases
of the European Society of Cardiology. Guidelines on the diagnosis
and management of pericardial diseases executive summary; The Task
Force on the Diagnosis and Management of Pericardial Diseases of
the European Society of Cardiology. Eur Heart J. 25:587–610. 2004.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Mayosi BM, Burgess LJ and Doubell AF:
Tuberculous pericarditis. Circulation. 112:3608–3616. 2005.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Bertrand D, Desbuissons G, Pallet N, et
al: Sirolimus therapy may cause cardiac tamponade. Transpl Int.
26:e4–e7. 2013. View Article : Google Scholar : PubMed/NCBI
|
6
|
Maisch B: Recurrent pericarditis:
mysterious or not so mysterious? Eur Heart J. 26:631–633. 2005.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Gianni F and Solbiati M; Gruppo di
Autoformazione Metodologica (GrAM). Colchicine is safe and
effective for secondary prevention of recurrent pericarditis.
Intern Emerg Med. 7:181–182. 2012. View Article : Google Scholar : PubMed/NCBI
|
8
|
Markel G, Imazio M, Brucato A and Adler Y:
Prevention of recurrent pericarditis with colchicine in 2012. Clin
Cardiol. 36:125–128. 2013. View Article : Google Scholar : PubMed/NCBI
|
9
|
Imazio M, Brucato A, Cemin R, et al; CORP
(COlchicine for Recurrent Pericarditis) Investigators. Colchicine
for recurrent pericarditis (CORP): a randomized trial. Ann Intern
Med. 155:409–414. 2011. View Article : Google Scholar : PubMed/NCBI
|
10
|
Imazio M, Bobbio M, Cecchi E, et al:
Colchicine as first-choice therapy for recurrent pericarditis:
Results of the CORE (COlchicine for REcurrent pericarditis) trial.
Arch Intern Med. 165:1987–1991. 2005. View Article : Google Scholar : PubMed/NCBI
|
11
|
Imazio M, Spodick DH, Brucato A, Trinchero
R and Adler Y: Controversial issues in the management of
pericardial diseases. Circulation. 121:916–928. 2010. View Article : Google Scholar : PubMed/NCBI
|
12
|
Artom G, Koren-Morag N, Spodick DH, et al:
Pretreatment with corticosteroids attenuates the efficacy of
colchicine in preventing recurrent pericarditis: a multi-centre
all-case analysis. Eur Heart J. 26:723–727. 2005. View Article : Google Scholar : PubMed/NCBI
|
13
|
Bouquié R, Deslandes G, Renaud C, et al:
Colchicine-induced rhabdomyolysis in a heart/lung transplant
patient with concurrent use of cyclosporin, pravastatin, and
azithromycin. J Clin Rheumatol. 17:28–30. 2011.PubMed/NCBI
|
14
|
Garrouste C, Philipponnet C, Kaysi S, et
al: Severe colchicine intoxication in a renal transplant recipient
on cyclosporine. Transplant Proc. 44:2851–2852. 2012. View Article : Google Scholar : PubMed/NCBI
|
15
|
Llaudó I, Colom H, Giménez-Bonafé P, et
al: Do drug transporter (ABCB1) SNPs and P-glycoprotein function
influence cyclosporine and macrolides exposure in renal transplant
patients? Results of the pharmacogenomic substudy within the
symphony study. Transpl Int. 26:177–186. 2013.
|